Retraction: Potential Mechanisms Linking Cholesterol to Alzheimer's Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle (Journal of Alzheimer s Disease (2008) 15: 4 (673-684) DOI: 10.3233/JAD-2008-15412);Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscle

Journal of Alzheimer's Disease

Volumn 15, Issue 4, 2008, Pages 673-684

  Ghribi, Othman ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

27 hydroxycholesterol; Alzheimer's disease; Amyloid ; ATP binding cassette transporters; Blood brain barrier; Cholesterol; Inclusion body myositis; Rabbit

Indexed keywords

26 HYDROXYCHOLESTEROL; ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER A2; ABC TRANSPORTER G1; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; CAFFEINE; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER X RECEPTOR AGONIST; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL INCLUSION; CELLULAR DISTRIBUTION; CEREBROSPINAL FLUID LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; HYPERCHOLESTEROLEMIA; INCLUSION BODY MYOSITIS; MYOSITIS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RABBIT; REVIEW; SKELETAL MUSCLE; LEPORIDAE; RETRACTION NOTICE; TOMBSTONE;

EID: 58149396136     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-239016     Document Type: Erratum

References (105)

1. J.C. Antoine, M. Tommasi, S. Boucheron, P. Convers, B. Laurent and D. Michel, Pathology of roots, spinal cord and brainstem in syringomyelia-like syndrome of Tangier disease, J Neurol Sci 106 (1991), 179-185.
2. Z. Arvanitakis, J.A. Schneider, R.S. Wilson, J.L. Bienias, J.F. Kelly, D.A. Evans and D.A. Bennett, Statins, incident Alzheimer disease, change in cognitive function, and neuropathology, Neurology 70 (2008), 1795-1802.
3. V. Askanas and W.K. Engel, Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease, J Neuropathol Exp Neurol 60 (2001), 1-14.
4. B.M. Austen, C. Sidera, C. Liu and E. Frears, The role of intracellular cholesterol on the processing of the beta-amyloid precursor protein, J Nutr Health Aging 7 (2003), 31-36.
5. G. Bartzokis, Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease, Neurobiol Aging 25 (2004), 5-18.
6. S.W. Beaven and P. Tontonoz, Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia, Ann Rev Med 57 (2006), 313-329.
7. I. Bjorkhem and S. Meaney, Brain cholesterol: long secret life behind a barrier, Arterioscler Thromb Vasc Biol 24 (2004), 806-815.
8. I. Bjorkhem, S. Meaney and U. Diczfalusy, Oxysterols in human circulation: which role do they have? Curr Opin Lipidol 13 (2002), 247-253.
9. G.J. Brewer, Isolation and culture of adult rat hippocampal neurons, J Neurosci Meth 71 (1997), 143-155.
10. A.J. Brown and W. Jessup, Oxysterols and atherosclerosis, Atherosclerosis 142 (1999), 1-28.
11. J. Brown, III, C. Theisler, S. Silberman, D. Magnuson, N. Gottardi-Littell, J.M. Lee, D. Yager, J. Crowley, K. Sambamurti, M.M. Rahman, A.B. Reiss, C.B. Eckman and B. Wolozin, Differential expression of cholesterol hydroxylases in Alzheimer's disease, J Biol Chem 279 (2004), 34674-34681.
12. M.P. Burns, W.J. Noble, V. Olm, K. Gaynor, E. Casey, J. LaFrancois, L.Wang and K. Duff, Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques, Brain Res Mol Brain Res 110 (2003), 119-125.
13. C.M. Carlsson, C.E. Gleason, T.M. Hess, K.A. Moreland, H.M. Blazel, R.L. Koscik, N.T. Schreiber, S.C. Johnson, C.S. Atwood, L. Puglielli, B.P. Hermann, P.E. McBride, J.H. Stein, M.A. Sager and S. Asthana, Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease, J Alzheimers Dis 13 (2008), 187-197.
14. X.Chen, J.W. Gawryluk, J.F. Wagener, O. Ghribi and J.D. Geiger, Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease, J Neuroinflammation 5 (2008), 12.
15. X. Chen, O. Ghribi and J.D. Geiger, Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis, Am J Physiol Regul Integr Comp Physiol 294 (2008), 829-835.
16. C.A. Colton, M.P. Vitek, D.A. Wink, Q. Xu, V. Cantillana, M.L. Previti, W.E. Van Nostrand, J.B. Weinberg and H. Dawson, NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease, Proc Natl Acad Sci USA 103 (2006), 12867-12872.
17. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines and M.A. Pericak-Vance, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science 261 (1993), 921-923.
18. J.M. Cordy, I. Hussain, C. Dingwall, N.M. Hooper and A.J. Turner, Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein, Proc Natl Acad Sci USA 100 (2003), 11735-11740.
19. O.P. Dall'Igna, L.O. Porciuncula, D.O. Souza, R.A. Cunha and D.R. Lara, Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity, Br J Pharmacol 138 (2003), 1207-1209.
20. R. Deane, Z.Wu, A. Sagare, J. Davis, Y.S. Du, K. Hamm, F. Xu, M. Parisi, B. LaRue, H.W. Hu, P. Spijkers, H. Guo, X. Song, P.J. Lenting, W.E. Van Nostrand and B.V. Zlokovic, LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms, Neuron 43 (2004), 333-344.
21. R. Deane, Z.Wu and B.V. Zlokovic, RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier, Stroke 35 (2004), 2628-2631.
22. R. Distl, V. Meske and T.G. Ohm, Tangle-bearing neurons contain more free cholesterol than adjacent tangle-free neurons, Acta Neuropathol (Berl) 101 (2001), 547-554.
23. M. Eto, K. Watanabe, N. Chonan and K. Ishii, Familial hypercholesterolemia and apolipoprotein E4, Atherosclerosis 72 (1988), 123-128.
24. K. Fassbender, M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, P. Keller, H. Runz, S. Kuhl, T. Bertsch, K. von Bergmann, M. Hennerici, K. Beyreuther and T. Hartmann, Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo, Proc Natl Acad Sci USA 98 (2001), 5856-5861.
25. E.R. Frears, D.J. Stephens, C.E.Walters, H. Davies and B.M. Austen, The role of cholesterol in the biosynthesis of betaamyloid, Neuroreport 10 (1999), 1699-1705.
26. X. Fu, J.G. Menke, Y. Chen, G. Zhou, K.L. MacNaul, S.D. Wright, C.P. Sparrow and E.G. Lund, 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterolloaded cells, J Biol Chem 276 (2001), 38378-38387.
27. J.L. Galbete, T.R. Martin, E. Peressini, P. Modena, R. Bianchi and G. Forloni, Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway, Biochem J 348 (2000), 307-313.
28. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A.L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. LaPointe, R. Miller, R.W. Berry, L.I. Binder and V.L. Cryns, Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease, Proc Natl Acad Sci USA 100 (2003), 10032-10037.
29. O. Ghribi, Preservation of the blood brain barrier integrity may underlie neuroprotective effects of statins in Alzheimer's disease, J Alzheimers Dis 10 (2006), 407-408.
30. O. Ghribi, M.Y. Golovko, B. Larsen, M. Schrag and E.J. Murphy, Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets, J Neurochem 99 (2006), 438-449.
31. O. Ghribi, M.M. Herman and J. Savory, Lithium inhibits Abeta-induced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation, J Neurosci Res 71 (2003), 853-862.
32. O. Ghribi, B. Larsen, M. Schrag and M.M. Herman, High cholesterol content in neurons increases BACE, betaamyloid, and phosphorylated tau levels in rabbit hippocampus, Exp Neurol 200 (2006), 460-467.
33. O. Ghribi, P. Prammonjago, M.M. Herman, N.K. Spaulding and J. Savory, Abeta(1-42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau, Brain Res Mol Brain Res 119 (2003), 201-206.
34. M. Goedert, W.J. Strittmatter and A.D. Roses, Alzheimer's disease. Risky apolipoprotein in brain, Nature 372 (1994), 45-46.
35. J. Gotz, F. Chen, D.J. van and R.M. Nitsch, Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils, Science 293 (2001), 1491-1495.
36. S.M. Greenberg, E.H. Koo, D.J. Selkoe, W.Q. Qiu and K.S. Kosik, Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation, Proc Natl Acad Sci USA 91 (1994), 7104-7108.
37. M. Heverin, N. Bogdanovic, D. Lutjohann, T. Bayer, I. Pikuleva, L. Bretillon, U. Diczfalusy, B. Winblad and I. Bjorkhem, Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease, J Lipid Res 45 (2004), 186-193.
38. M. Heverin, S. Meaney, D. Lutjohann, U. Diczfalusy, J. Wahren and I. Bjorkhem, Crossing the barrier: Net flux of 27-hydroxycholesterol into the human brain, J Lipid Res 46 (2005), 1047-1052.
39. V. Hirsch-Reinshagen, L.F. Maia, B.L. Burgess, J.F. Blain, K.E. Naus, S.A. McIsaac, P.F. Parkinson, J.Y. Chan, G.H. Tansley, M.R. Hayden, J. Poirier, N.W. van and C.L. Wellington, The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease, J Biol Chem 280 (2005), 43243-43256.
40. R.M. Holsinger, C.A. McLean, K. Beyreuther, C.L. Masters and G. Evin, Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease, Ann Neurol 51 (2002), 783-786.
41. N.B. Javitt, Cholesterol, hydroxycholesterols, and bile acids, Biochem Biophys Res Commun 292 (2002), 1147-1153.
42. Q. Jiang, C.Y. Lee, S. Mandrekar, B. Wilkinson, P. Cramer, N. Zelcer, K. Mann, B. Lamb, T.M. Willson, J.L. Collins, J.C. Richardson, J.D. Smith, T.A. Comery, D. Riddell, D.M. Holtzman, P. Tontonoz and G.E. Landreth, ApoE promotes the proteolytic degradation of Abeta, Neuron 58 (2008), 681-693.
43. H. Jick, G.L. Zornberg, S.S. Jick, S. Seshadri and D.A. Drachman, Statins and the risk of dementia, Lancet 356 (2000), 1627-1631.
44. W.S. Kim, S.L. Chan, A.F. Hill, G.J. Guillemin and B. Garner, Impact of 27-Hydroxycholesterol on Amyloid-β Peptide Production and ATP-Binding Cassette Transporter Expression in Primary Human Neurons, J Alzheimers Dis 16 (2009), in press.
45. W.S. Kim, G.J. Guillemin, E.N. Glaros, C.K. Lim and B. Garner, Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells, Neuroreport 17 (2006), 891-896.
46. W.S. Kim, C.S. Weickert and B. Garner, Role of ATP-binding cassette transporters in brain lipid transport and neurological disease, J Neurochem 104 (2008), 1145-1166.
47. M. Kivipelto, E.L. Helkala, T. Hanninen, M.P. Laakso, M. Hallikainen, K. Alhainen, H. Soininen, J. Tuomilehto and A. Nissinen, Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study, Neurology 56 (2001), 1683-1689.
48. R. Koldamova, M. Staufenbiel and I. Lefterov, Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice, J Biol Chem 280 (2005), 43224-43235.
49. R. Koldamova, I.M. Lefterov, M.D. Ikonomovic, J. Skoko, P.I. Lefterov, B.A. Isanski, S.T. DeKosky and J.S. Lazo, 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion, J Biol Chem 278 (2003), 13244-13256.
50. B. Kwak, F. Mulhaupt, S. Myit and F. Mach, Statins as a newly recognized type of immunomodulator, Nat Med 6 (2000), 1399-1402.
51. Y. Lange, J.Ye, M. Rigney and T.L. Steck, Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol, J Lipid Res 40 (1999), 2264-2270.
52. O. Levi, D. Lutjohann, A. Devir, B.K. von, T. Hartmann and D.M. Michaelson, Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation, J Neurochem 95 (2005), 987-997.
53. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton and E. McGowan, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science 293 (2001), 1487-1491.
54. T. Liu, G. Perry, H.W. Chan, G. Verdile, R.N. Martins, M.A. Smith and C.S. Atwood, Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression, J Neurochem 88 (2004), 554-563.
55. E.G. Lund, J.M. Guileyardo and D.W. Russell, cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain, Proc Natl Acad Sci USA 96 (1999), 7238-7243.
56. D. Lutjohann, O. Breuer, G. Ahlborg, I. Nennesmo, A. Siden, U. Diczfalusy and I. Bjorkhem, Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation, Proc Natl Acad Sci USA 93 (1996), 9799-9804.
57. D. Lutjohann, A. Papassotiropoulos, I. Bjorkhem, S. Locatelli, M. Bagli, R. D. Oehring, U. Schlegel, F. Jessen, M. L. Rao, K. von Bergmann and R. Heun, Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients, J Lipid Res 41 (2000) 195-198.
58. J. Ma, A. Yee, H.B. Brewer, S. Jr. Das and H. Potter, Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer betaprotein into filaments, Nature 372 (1994), 92-94.
59. R.W. Mahley, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science 240 (1988), 622-630.
60. L. Maia, A. deMendonca, Does caffeine intake protect from Alzheimer's disease?, Eur J Neurol 9 (2002), 377-382.
61. L. Marlow, M. Cain, M.A. Pappolla and K. Sambamurti, Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP), J Mol Neurosci 20 (2003), 233-239.
62. T.J. McNulty and C.W. Taylor, Caffeine-stimulated Ca2+ release from the intracellular stores of hepatocytes is not mediated by ryanodine receptors, Biochem J 291 (1993), 799-801.
63. P.I. Moreira, K. Honda, X. Zhu, A. Nunomura, G. Casadesus, M.A. Smith and G. Perry, Brain and brawn: parallels in oxidative strength, Neurology 66 (2006), 97-101.
64. A. Mudher and S. Lovestone, Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci 25 (2002), 22-26.
65. K. Murakami, M. Shimizu, N. Yamada, S. Ishibashi, H. Shimano, Y. Yazaki and Y. Akanuma, Apolipoprotein E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM, Diabetes Care 16 (1993), 564-569.
66. S. Oddo, A. Caccamo, M. Kitazawa, B.P. Tseng and F.M. LaFerla, Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease, Neurobiol Aging 24 (2003), 1063-1070.
67. A. Papassotiropoulos, D. Lutjohann, M. Bagli, S. Locatelli, F. Jessen, M.L. Rao, W. Maier, I. Bjorkhem, K. vonBergmann and R. Heun, Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease, Neuroreport 11 (2000), 1959-1962.
68. A. Papassotiropoulos, J.R. Streffer, M. Tsolaki, S. Schmid, D. Thal, F. Nicosia, V. Iakovidou, A. Maddalena, D. Lutjohann, E. Ghebremedhin, T. Hegi, T. Pasch, M. Traxler, A. Bruhl, L. Benussi, G. Binetti, H. Braak, R.M. Nitsch and C. Hock, Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism, Arch Neurol 60 (2003), 29-35.
69. D. Paris, K.P. Townsend, J. Humphrey, D.F. Obregon, K. Yokota and M. Mullan, Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae, Atherosclerosis 161 (2002), 293-299.
70. F.W. Pfrieger, Cholesterol homeostasis and function in neurons of the central nervous system, Cell Mol Life Sci 60 (2003), 1158-1171.
71. J. Poirier, A. Baccichet, D. Dea and S. Gauthier, Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats, Neuroscience 55 (1993), 81-90.
72. H.W. Querfurth, N.J. Haughey, S.C. Greenway, P.W. Yacono, D.E. Golan and J.D. Geiger, Expression of ryanodine receptors in human embryonic kidney (HEK293) cells, Biochem J 334 (1998), 79-86.
73. M. Racchi, R. Baetta, N. Salvietti, P. Ianna, G. Franceschini, R. Paoletti, R. Fumagalli, S. Govoni, M. Trabucchi and M. Soma, Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content, Biochem J 322 (1997), 893-898.
74. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek and A. Ferreira, Tau is essential to beta -amyloid-induced neurotoxicity, Proc Natl Acad Sci USA 99 (2002), 6364-6369.
75. T.D. Rea, J.C. Breitner, B.M. Psaty, A.L. Fitzpatrick, O.L. Lopez, A.B. Newman, W.R. Hazzard, P.P. Zandi, G.L. Burke, C.G. Lyketsos, C. Bernick and L.H. Kuller, Statin use and the risk of incident dementia: the Cardiovascular Health Study, Arch Neurol 62 (2005), 1047-1051.
76. L.M. Refolo, B. Malester, J. LaFrancois, T. Bryant-Thomas, R. Wang, G.S. Tint, K. Sambamurti, K. Duff and M.A. Pappolla, Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model, Neurobiol Dis 7 (2000), 321-331.
77. R.G. Riekse, G. Li, E.C. Petrie, J.B. Leverenz, D. Vavrek, S. Vuletic, J.J. Albers, T.J. Montine, V.M. Lee, M. Lee, P. Seubert, D. Galasko, G.D. Schellenberg, W.R. Hazzard and E.R. Peskind, Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid, J Alzheimers Dis 10 (2006), 399-406.
78. D.W. Russell, Oxysterol biosynthetic enzymes, Biochim Biophys Acta 1529 (2000), 126-135.
79. A. Saheki, T. Terasaki, I. Tamai and A. Tsuji, In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, Pharm Res 11 (1994), 305-311.
80. G. Saher, B. Brugger, C. Lappe-Siefke, W. Mobius, R. Tozawa, M.C. Wehr, F. Wieland, S. Ishibashi and K.A. Nave, High cholesterol level is essential for myelin membrane growth, Nat Neurosci 8 (2005), 468-475.
81. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan and M.J. Alberts, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology 43 (1993), 1467-1472.
82. G. Schmitz and W. E. Kaminski, ABCA2: a candidate regulator of neural transmembrane lipid transport, Cell Mol Life Sci 59 (2002), 1285-1295.
83. M. Schrag, S. Sharma, H. Brown-Borg and O. Ghribi, Hippocampus of Ames dwarf mice is resistant to beta-amyloid-induced tau hyperphosphorylation and changes in apoptosisregulatory protein levels, Hippocampus 18 (2008), 239-244.
84. F.S. Shie, L.W. Jin, D.G. Cook, J.B. Leverenz and R.C. LeBoeuf, Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice, Neuroreport 13 (2002), 455-459.
85. M. Simons, P. Keller, B. De Strooper, K. Beyreuther, C. G. Dotti and K. Simons, Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons, Proc Natl Acad Sci USA 95 (1998), 6460-6464.
86. M. Sjogren, K. Gustafsson, S. Syversen, A. Olsson, A. Edman, P. Davidsson, A. Wallin and K. Blennow, Treatment with simvastatin in patients with Alzheimer's disease lowers both alpha- and beta-cleaved amyloid precursor protein, Dement Geriatr Cogn Disord 16 (2003), 25-30.
87. D.L. Sparks, The early and ongoing experience with the cholesterol-fed rabbit as a model of Alzheimer's disease: the old, the new and the pilot, J Alzheimers Dis 15(4) (2008), 641-656.
88. D.L. Sparks, H. Liu, D.R. Gross and S.W. Scheff, Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol, Neurosci Lett 187 (1995), 142-144.
89. D.L. Sparks, S.W. Scheff, J.C. Hunsaker, III, H. Liu, T. Landers and D.R. Gross, Induction of Alzheimer-like betaamyloid immunoreactivity in the brains of rabbits with dietary cholesterol, Exp Neurol 126 (1994), 88-94.
90. L. Stoppini, P.A. Buchs and D. Muller, A simple method for organotypic cultures of nervous tissue, J Neurosci Methods 37 (1991), 173-182.
91. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen and A.D. Roses, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA 90 (1993), 1977-1981.
92. O. Stuve, S. Youssef, L. Steinman and S.S. Zamvil, Statins as potential therapeutic agents in neuroinflammatory disorders, Curr Opin Neurol 16 (2003), 393-401.
93. Y. Sun, J. Yao, T.W. Kim and A.R. Tall, Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion, J Biol Chem 278 (2003), 27688-27694.
94. Y.X. Sun, M. Crisby, S. Lindgren and S. Janciauskiene, Pravastatin inhibits pro-inflammatory effects of Alzheimer's peptide Abeta(1-42) in glioma cell culture in vitro, Pharmacol Res 47 (2003), 119-126.
95. S. Sharma, J. Prasanthi, E. Schommer, G. Feist and O. Ghribi, Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol Dis (2008), in press.
96. A. Takashima, T. Honda, K. Yasutake, G. Michel, O. Murayama, M. Murayama, K. Ishiguro and H. Yamaguchi, Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons, Neurosci Res 31 (1998), 317-323.
97. G.H. Tansley, B.L. Burgess, M.T. Bryan, Y. Su, V. Hirsch-Reinshagen, J. Pearce, J.Y. Chan, A. Wilkinson, J. Evans, K.E. Naus, S. McIsaac, K. Bromley, W. Song, H.C. Yang, N. Wang, R.B. DeMattos and C.L. Wellington, The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of beta-amyloid precursor protein, J Lipid Res 48 (2007), 1022-1034.
98. S.E. Wahrle, H. Jiang, M. Parsadanian, R.E. Hartman, K.R. Bales, S.M. Paul and D.M. Holtzman, Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease, J Biol Chem 280 (2005), 43236-43242.
99. L. Wang, G.U. Schuster, K. Hultenby, Q. Zhang, S. Andersson and J.A. Gustafsson, Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration, Proc Natl Acad Sci USA 99 (2002), 13878-13883.
100. B. Wolozin, Cholesterol and the biology of Alzheimer's disease, Neuron 41 (2004), 7-10.
101. B. Wolozin, J. Brown, III, C. Theisler and S. Silberman, The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease, CNS Drug Rev 10 (2004), 127-146.
102. D.S. Woodruff-Pak, A. Agelan and V.L. Del, A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels, J Alzheimers Dis 11 (2007), 371-383.
103. L.B. Yang, K. Lindholm, R. Yan, M. Citron, W. Xia, X.L. Yang, T. Beach, L. Sue, P.Wong, D. Price, R. Li and Y. Shen, Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease, Nat Med 9 (2003), 3-4.
104. P.P. Zandi, D.L. Sparks, A.S. Khachaturian, J. Tschanz, M. Norton, M. Steinberg, K.A.Welsh-Bohmer and J.C. Breitner, Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study, Arch Gen Psychiatry 62 (2005), 217-224.
105. C. Zhou, L. Zhao, N. Inagaki, J. Guan, S. Nakajo, T. Hirabayashi, S. Kikuyama and S. Shioda, Atp-binding cassette transporter ABC2/ABCA2 in the rat brain: a novel mammalian lysosome-associated membrane protein and a specific marker for oligodendrocytes but not for myelin sheaths, J Neurosci 21 (2001), 849-857.